Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer
Clinical trial NCT03162224 · COMPLETED
Trial details
- NCT number
- NCT03162224
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2021-03-19
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.